Switch to:
Alexion Pharmaceuticals Inc (NAS:ALXN)
Research and Development
$434 Mil (TTM As of Mar. 2014)

This is the expense the company spent on research and development. Alexion Pharmaceuticals Inc's research and development for the three months ended in Mar. 2014 was $191 Mil. Its research and development for the trailing twelve months (TTM) ended in Mar. 2014 was $434 Mil.


Definition

This is the expense the company spent on research and development.

Alexion Pharmaceuticals Inc Research & Development for the trailing twelve months (TTM) ended in Mar. 2014 was 68.563 (Jun. 2013 ) + 88.209 (Sep. 2013 ) + 85.785 (Dec. 2013 ) + 191.457 (Mar. 2014 ) = $434 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Related Terms

Gross Profit


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Alexion Pharmaceuticals Inc Annual Data

Jul04Jul05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
Research & Development 60918369638298137223317

Alexion Pharmaceuticals Inc Quarterly Data

Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14
Research & Development 344560546375698886191
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide